Proceedings of the National Academy of Sciences · 2012 · 221 citations · 32 references
Life SciencesCell BiologyMolecular BiologyEnzymologyMolecular OncologyNuclear OrganizationProtein DegradationRibosome BiogenesisNucleolar FeaturesNucleolar OrganizationNucleolar Ribosome BiogenesisProteasomal TurnoverProteasome-mediated DegradationRibosomal RnasRibosomal StressRibosome Biogenesis Factors
Impairment of ribosomal biogenesis can activate the p53 protein independently of DNA damage. The ability of ribosomal proteins L5, L11, L23, L26, or S7 to bind Mdm2 and inhibit its ubiquitin ligase activity has been suggested as a critical step in p53 activation under these conditions. Here, we report that L5 and L11 are particularly important for this response. Whereas several other newly synthesized ribosomal proteins are degraded by proteasomes upon inhibition of Pol I activity by actinomycin D, L5 and L11 accumulate in the ribosome-free fraction where they bind to Mdm2. This selective accumulation of free L5 and L11 is due to their mutual protection from proteasomal degradation. Furthermore, the endogenous, newly synthesized L5 and L11 continue to be imported into nucleoli even after nucleolar disruption and colocalize with Mdm2, p53, and promyelocytic leukemia protein. This suggests that the disrupted nucleoli may provide a platform for L5- and L11-dependent p53 activation, implying a role for the nucleolus in p53 activation by ribosomal biogenesis stress. These findings may have important implications with respect to understanding the pathogenesis of diseases caused by impaired ribosome biogenesis.
32
Jens Andersen, Yun Wah Lam, Anthony K. L. Leung et al. · Nature · 2005 · 1.1K citations
Directed Proteomic Analysis of the Human Nucleolus
Jens Andersen, Carol E. Lyon, Archa H. Fox et al. · Current Biology · 2002 · 1K citations · Full text
Regulation of HDM2 activity by the ribosomal protein L11
Marion Lohrum, Robert L. Ludwig, Michael H.G. Kubbutat et al. · Cancer Cell · 2003 · 616 citations · Full text
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
Ariel Cohen, Naama Geva‐Zatorsky, Eran Eden et al. · Science · 2008 · 615 citations